Found 11 matching trials
A Study in Healthy Male Subjects Designed to Assess the Mass Balance Recovery and Pharmacokinetics of 14C TZP-101
PHASE1A study to investigate the mass balance recovery and pharmacokinetics of 14...
Location
Quotient Clinical
Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis
PHASE2The purpose of this study is to determine whether TZP-101 is effective in t...
Location
California Pacific Medical Center
Evaluation of the Pharmacokinetics of Ulimorelin in Subjects With Hepatic Impairment and Healthy Subjects
PHASE1Evaluation of the effect of hepatic impairment on the pharmacokinetics of u...
Location
Univerzitna nemocnica Bratislava, nem.
Study to Examine the Effect of Ulimorelin on the Pharmacokinetics of Midazolam in Healthy Volunteers
PHASE1An open-label, single centre, randomised, cross-over study to examine the e...
Location
BioKinetic Europe Ltd
Study to Evaluate the Safety of Post-Operative TZP-101 (IV Ulimorelin) After Partial Bowel Resection
PHASE3A study to evaluate the safety of TZP-101 in comparison with placebo when a...
Location
Multiple Locations
A Study to Assess Ulimorelin in Healthy Subjects
PHASE1A Phase I dose escalation study involving healthy subjects....
Location
Multiple Locations
Safety and Efficacy of IV Infusion of TZP-101 for POI After Major Open Abdominal Surgery
PHASE2The purpose of this study is to determine whether TZP-101 is effective in t...
Location
Office of Dr. Phillip Fleshner
Efficacy, Safety, and Pharmacokinetics (PK) Study of Ulimorelin in Patients With Enteral Feeding Intolerance (EFI): The PROMOTE Trial
PHASE2The purpose of this study is to evaluate the effect Ulimorelin in patients ...
Location
Multiple Locations
Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis
PHASE1The purpose of this study is to determine whether TZP-101 is safe in people...
Ulimorelin Study of Efficacy and Safety (ULISES 007)
PHASE3Post-operative administration of ulimorelin is expected to reduce time to r...
Location
Fountain Valley Regional Hospital